Sabinsa Notifies Alchem as to Status of Its Forskolin(ForsLean®) Patent
Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin (ForsLean®), and…
Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin (ForsLean®), and…
Sabinsa Corporation today announced that it has secured a patent in Canada for its branded ingredient ForsLean® , a standardized extract of Coleus forskohlii…
Sabinsa Corporation announced today that it has sued BioGreen NutraChem Inc. in the United States District Court in the Eastern District of New York for infring…
Sabinsa Corporation announced today that it has successfully concluded its patent infringement lawsuit against DNP International, Inc. in the United States Dist…
Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, was awarded…
A recent study published in the August 2005 Journal of Obesity Research entitled “Body Composition and Hormonal Adaptations…
Sabinsa Corporation has once again successfully protected its intellectual property (IP). Mark C. Sysler, Sabinsa’s Sr. EVP for Marketing and Sales today anno…
Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit th…
Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit…
Sami Labs, Ltd., the research and manufacturing arm of Sabinsa Corporation, was recently notified that it will be the recipient of two Export awards for the year…